Single-cell eQTL Mendelian randomization reveals the monocyte-associated PRKCB–CTSL axis as a candidate regulatory pathway and potential therapeutic target in rheumatoid arthritis
Clinical Rheumatology · 2026-12 · 45 (12) · 7231-7251
DOI: 10.1007/s10067-026-08482-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Rheumatology, online erschienen am 19.10.2026. Verfasst von Pengli Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Second Clinical Medical …. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Monocytes, Protein Kinase C beta, Quantitative Trait Loci. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Transportation of Sichuan Province.
Abstract (Originalsprache)
Objectives
Rheumatoid arthritis (RA) involves persistent immune dysregulation, but cell-specific genetically regulated pathways remain unclear. We integrated cell-specific genetic and multi-omics evidence to prioritize candidate regulatory pathways. Methods cis-eQTLs from 17 immune-cell populations were integrated with RA GWAS data by two-sample Mendelian randomization. Transcriptomics, WGCNA, and machine-learning feature selection identified convergent candidates. Single-cell and virtual perturbation analyses assessed cellular localization and downstream changes. Molecular docking and dynamics computationally prioritized compounds, and knockdown/rescue experiments evaluated the PRKCB–CTSL relationship.
Results
Eleven candidates had convergent genetic and transcriptomic support. PRKCB was retained by LASSO, SVM, and random forest and preferentially expressed in monocytes. Virtual perturbation implicated CTSL and antigen-processing/presentation pathways. PRKCB knockdown reduced CTSL expression and NF-κB phosphorylation, whereas CTSL restoration partially rescued NF-κB phosphorylation. Separately, structure-based analyses computationally prioritized ursodiol for the most favorable predicted PRKCB interaction among evaluated compounds.
Conclusions
Genetic, transcriptomic, single-cell, computational, and in vitro evidence supports monocyte-associated PRKCB–CTSL as a candidate regulatory pathway in RA. Further mechanistic and in vivo studies are required to establish its causal and pharmacological relevance. Key Points • Multi-omics analysis identified 11 key RA-associated targets. • RA was classified into two molecular subtypes with distinct immune features. • PRKCB was identified as the core target enriched in monocytes. • The PRKCB–CTSL axis may drive RA inflammation, and ursodiol showed therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Surgery, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Second Clinical Medical College of North Sichuan Medical College, No. 97 Renmin South Road, Sh…
- Department of Clinical Medicine, Ningxia Medical University, Hui Autonomous Region, Yinchuan, Ningxia, 750004, People's Republic of China.
- School of Basic Medicine and Forensic Medicine, North Sichuan Medical College, No.234 Fujiang Road, Shunqing District, Nanchong , Sichuan, 637000, China.
- North Sichuan Medical College, No. 234 Fu Jiang Road, Shunqing, Nanchong, 637000, Sichuan, People's Republic of China.
- North Sichuan Medical College, No. 234 Fu Jiang Road, Shunqing, Nanchong, 637000, Sichuan, People's Republic of China. 1428421664@qq.com.
Förderung
- Department of Transportation of Sichuan Province
Zitieren
APA
Wang, P., Shen, G., Liao, W., Wang, R., Zhang, L., Zhao, M., Zhang, D., Huang, N., & Dai, Y. (2026). Single-cell eQTL Mendelian randomization reveals the monocyte-associated PRKCB–CTSL axis as a candidate regulatory pathway and potential therapeutic target in rheumatoid arthritis. Clinical Rheumatology, 45(12), 7231-7251. https://doi.org/10.1007/s10067-026-08482-4
Vancouver
Wang P, Shen G, Liao W, Wang R, Zhang L, Zhao M, et al. Single-cell eQTL Mendelian randomization reveals the monocyte-associated PRKCB–CTSL axis as a candidate regulatory pathway and potential therapeutic target in rheumatoid arthritis. Clinical Rheumatology. 2026;45(12):7231-7251. doi:10.1007/s10067-026-08482-4
BibTeX
@article{Wang2026,
author = {Wang, Pengli and Shen, Guohang and Liao, Wenhua and Wang, Ruoyan and Zhang, Li and Zhao, Mingjia and Zhang, Dong and Huang, Nanxiang and Dai, Yupei},
title = {Single-cell eQTL Mendelian randomization reveals the monocyte-associated PRKCB–CTSL axis as a candidate regulatory pathway and potential therapeutic target in rheumatoid arthritis},
journal = {Clinical Rheumatology},
year = {2026},
volume = {45},
number = {12},
pages = {7231--7251},
doi = {10.1007/s10067-026-08482-4}
}
EUVIMED